Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA, Imaging Industry Hear Advice On Radiation Safety Improvements

This article was originally published in The Gray Sheet

Executive Summary

Groups representing radiologists, imaging technicians and physicists are urging industry to offer more tools to protect patients from potential radiation overexposure during medical imaging

You may also be interested in...



NIH Leads Aggressive Push To Lower Radiation Doses In CT Scans

An imaging group within the National Institutes of Health is stepping up its response to public concerns over radiation exposure with an aggressive effort to reduce the effective radiation dose from a routine CT exam by 80%-90%.

NIH Leads Aggressive Push To Lower Radiation Doses In CT Scans

An imaging group within the National Institutes of Health is stepping up its response to public concerns over radiation exposure with an aggressive effort to reduce the effective radiation dose from a routine CT exam by 80%-90%.

Device Background Checks Could Reduce Safety Hazards - ECRI Institute

Safety hazards could be greatly curtailed if more hospitals ran thorough background checks on new medical equipment before they purchase or commission them, according to executives at a non-profit research group

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel